{"name":"Nested Therapeutics, Inc","slug":"nested-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQaktuZXdhYm5TRERzZl9WTjBuSjNWM0NvLWFyazI0WUoybUF3Wlg2YnJqSUJqMmlFdjNMemhPWWZkbWVYMi1lVW1rR1N0WTdkTGMtTGZBMkFRLVVBX0RuNnctRnI3ODdMUFZOTk5pQW5YV01SRXpBT0lHeUctcVMwWE1TMTZpTzBSc3ZxUHBkdHFWaFlZMzl5N01GNU5za0h2a0xqeDFZWHBnSGZDenFKTUVfZFpqLTNjVjBCSHpmbURtQTJXcFhkQTZQa1BHTVFINVlBSVhQZ1FnZ3F4a3FhV09URUdldDBvYlN4bXJR?oc=5","date":"2026-02-23","type":"pipeline","source":"BioSpace","summary":"Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors - BioSpace","headline":"Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"nature.com","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - nature.com","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNT1RDcEVpdWtCZmlYcnkyTzNJaGdBQ2ZzRFoyVHVtamcwQzAyampKM1BOWURZeE0xNFMyMy15cV8wQjROdG9ZRUZwSVpjcTBQRno2ekNCZENrSk9FQURIajhyYzE2VUh6RFJhRkQ5R1NRa1FOUXJXbHhBMzAzbEE5dFJpcWJBSEZqcnRzQ0lodjVFNmlMUy1KeEk3VkI?oc=5","date":"2025-04-28","type":"regulatory","source":"Grand View Research","summary":"Molecular Glues Approved Drugs And Pipeline Analysis - Grand View Research","headline":"Molecular Glues Approved Drugs And Pipeline Analysis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1sS3V1ZEktV1pGS1VvMHY5bHR0Y1FGenlPYS03a09QcWd3bTU4czNrZVBHcGtoaUlweElnRHlQQ0UzMGdkTDlBZHhJaVpiOU40VC1lUVljU1lLaEI4?oc=5","date":"2025-03-18","type":"pipeline","source":"EurekAlert!","summary":"WIN Consortium leading the future of precision cancer medicine - EurekAlert!","headline":"WIN Consortium leading the future of precision cancer medicine - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNS0xJRzdqU1hkaEV3c1BzZHd3V1BvUjFoLWo3aW80SktGMWdNaFBJYkViTE9YbkNxcy03WjNTTU1XbTlVMkdHWWdmeXJobFZIcnVVZ1BlcVJPX2VWenhyV2J4dFdodTBWcDZOTklYNDBvMXpURnZMQnhLa2d5WmcwWkRoTU53Nnd4aGFsY1c2MTU0SmZrUDhQeU14VkRMeXRNdW5nVU9Xal9Sd1JFZGRlMU5CMzNNTGlZSGJuUzhvWQ?oc=5","date":"2024-05-10","type":"trial","source":"The ASCO Post","summary":"Selective Targeting of PARP1 in Early-Phase Study Shows Activity in Breast Cancer - The ASCO Post","headline":"Selective Targeting of PARP1 in Early-Phase Study Shows Activity in Breast Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxQdEV6OGowbFo0SmNDZkpaZjRFX2UyTm5BdTZhSUozdjBrSW1ITnFUNUxMV1BWQ250M0dBNUViUmZxaFJDQW1XVXRJMVJIeXlzQ2Nkb2VOUU1Bbm80Y1c5aFR3RkRsRmNDMURrd3hXejR2cXBBcXR4R2EtUFl3SlJkTjhwSjhWZUV1bWxlc25yYzRTTjczejRDMkJwcFFZSjF2cHNEelRMVTdvblF3LWpXQnAtRHAta3VURmlhWEpsXzA4dnlySHVJVzJMeThGSkM3X21HNkRsWkFMa01rU2JkZ1pSRzY0dkdSWUNodGhFU2tsRUlFNWVVR244bHJmNktxNFZmWE5YdnBxdHU1VTVDRjN5anR3V3dKR0lNS1M3dWJJR2JCa2JIZ1lHMElXbjk4dDR6bk40dndqY1JrTlBVQ0o0OGJGQQ?oc=5","date":"2024-04-08","type":"trial","source":"PR Newswire","summary":"Nested Therapeutics Announces Oral Presentation of Preclinical Data for NST-628, a Novel, Fully Brain-Penetrant, Pan-RAF/MEK Molecular Glue, at the 2024 AACR Annual Meeting - PR Newswire","headline":"Nested Therapeutics Announces Oral Presentation of Preclinical Data for NST-628, a Novel, Fully Brain-Penetrant, Pan-RAF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNcFZJalBqbFIwR244Yjh5M2xydW9sanJ1VjhZeUlidFMzaWVjRzNkQjNiX0xxbWl0Z3RiNHlWRG9rcUo0NVNrTUZoNGtlbXVKVnhfN0FSMExLZ3c4R2tuaC1UTDRYUDViRkVYVFhoVkx1ZERBTm5TamFFLUJNNjMtaldXbUFrNE13SS0zMDhrQTcxNTNZZ2hsSEpqUGdUZ1ZQTlh6N2wyeXhES3JEbnRfc3BkY0s1SUNCZ3A1NUdDaVl6aFJhb1Y2QURVV1JVdm9xTFBRaDZ5YVExUklhaU1XQlRzYjBCTU1kMHRkeTItSTllc1pEbmFSUXFtWUFmVXJudkdYdDBLRzVqS3ZIQ1pkLVZLVGJnSGk4?oc=5","date":"2024-03-28","type":"regulatory","source":"PR Newswire","summary":"Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue - PR Newswire","headline":"Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5kRVRiU0ViWFZtanptMnluYzBjYl9RZ3MwWGpYMTB0V2UxaTlPd2VkRnFNT2Jqc1MzTFFpTWp3cHdPNWdWd0NUR0xmVnJzbTBoNERjMGZEaEc5QTNNUVZiTzN6dUFZd0xrakttZ0xzN1BXckh1VmFIMXUyZklmU1U?oc=5","date":"2024-02-01","type":"pipeline","source":"Contract Pharma","summary":"Drug Discovery Outsourcing in 2023 — A Recap - Contract Pharma","headline":"Drug Discovery Outsourcing in 2023 — A Recap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNOGZ3T3hyUk85SmJwb1ZQcklnb283SFJ3RE51VXNsTWRWQzdWbnRiZmgxOFNIOEI5M2lnSl85TkFNSl85SEd2dEhzMHgtbl9rbGVWaDVETkRCeUxpUzhRcWpra0dMM0FtSWs4TU5EeDFlUDgtaFlBZTZvZzA4OWNKaWpfcmtWck5TcndwOWg3d1VjOFp0OENGTE5Mc0ljc0k4UVVuSXdwUE1yOWNzOEFaRA?oc=5","date":"2022-10-06","type":"pipeline","source":"PR Newswire","summary":"Nested Therapeutics Launches With $125 Million Financing - PR Newswire","headline":"Nested Therapeutics Launches With $125 Million Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNc0FzZGxybVI1b2ZWRklmNXBIX2JTM3g3dFktbXplSVJkdHg2UWw0TjVnYzlUaGdNWlFjeU40dFdPb2ZNMlNmdG1oWmZaQkc2RWxHWnRkSkVSMFZ4elhOZUMwVmlFUWJCeUJVY0hpSDNiWjM5enhqTDREQjRZQzlUZy1wZVFlMTM1bzhBSUZaNGZ3MTQ0?oc=5","date":"2022-10-06","type":"pipeline","source":"BioPharma Dive","summary":"A Versant-backed biotech emerges to take on ‘overlooked’ cancer targets - BioPharma Dive","headline":"A Versant-backed biotech emerges to take on ‘overlooked’ cancer targets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPR2ZVcXluNmh0Y2o3MVpGa0xvREk0NGdDUUdLeEpvWDYzNGZjcm1qanN6NF9pcWJxa2J0aGQ5Z01SbEV3UXV0ZDZIODc0dGFUb3BFU19SajlvYXI3eFNmRjhVMG00WE4wS2pBbkU5d0VFbXgxQmZKaVdEdWRVMXItZlYtbThuTU8yM20ydmlGUnZERWlyWEhfd055OGx6ZVNkdmdHa1FCUHVSLUZoRlE?oc=5","date":"2022-10-06","type":"pipeline","source":"MedCity News","summary":"Versant-founded biotech Nested hatches with $90M and new take on cancer drugs - MedCity News","headline":"Versant-founded biotech Nested hatches with $90M and new take on cancer drugs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}